Health-related quality of life in pediatric patients after allogeneic SCT: Development of the PedsQL Stem Cell Transplant module and results of a pilot study

Bone Marrow Transplantation

Volumn 49, Issue 8, 2014, Pages 1093-1097

  Lawitschka, A ^a   Guclu E D ^a   Varni, J W ^b   Putz, M ^a   Wolff, D ^c   Pavletic, S ^d   Greinix, H ^e   Peters, C ^a   Felder Puig, R ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOGRAFT; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; FEMALE; GRAFT VS HOST DISEASE; HUMAN; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PILOT STUDY; PRESCHOOL CHILD; PSYCHOLOGY; QUALITY OF LIFE; STEM CELL TRANSPLANTATION; UNITED STATES;

ADOLESCENT; ADULT; ALLOGRAFTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CONSENSUS DEVELOPMENT CONFERENCES, NIH AS TOPIC; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; PILOT PROJECTS; QUALITY OF LIFE; STEM CELL TRANSPLANTATION; UNITED STATES;

EID: 84905682255     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.96     Document Type: Article

References (27)

1. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
2. Pavletic SZ, Lee SJ, Socie G, Vogelsang G. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant 2006; 38: 645-651.
3. Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12: 252-266.
4. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 2002; 94: 2090-2106.
5. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003; 3: 329-341.
6. Felder-Puig R, Baumgartner M, Topf R, Gadner H, Formann AK. Health-related quality of life in Austrian elementary school children. Med Care 2008; 46: 432-439.
7. Felder-Puig R, di Gallo A, Waldenmair M, Norden P, Winter A, Gadner H et al. Health-related quality of life of pediatric patients receiving allogeneic stem cell or bone marrow transplantation: results of a longitudinal, multi-center study. Bone Marrow Transplant 2006; 38: 119-126.
8. Felder-Puig R, Frey E, Proksch K, Varni JW, Gadner H, Topf R et al. Validation of the German version of the Pediatric Quality of Life Inventory (PedsQL) in childhood cancer patients off treatment and children with epilepsy. Qual Life Res 2004; 13: 223-234.
9. Weissberg-Benchell J, Zielinski TE, Rodgers S, Greenley RN, Askenazi D, Goldstein SL et al. Pediatric health-related quality of life: feasibility, reliability and validity of the PedsQL™ transplant module. Am J Transplant 2010; 10: 1686-1694.
10. Cheuk DKL, Mok ASP, Lee ACW, Chiang AKS, Ha SY, Lau YL et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant 2008; 42: 319-327.
11. Caocci G, Efficace F, Ciotti F, Roncarolo MG, Vacca A, Piras E et al. Prospecitve assessment of health-related quality of life in pediatric patients with betathalassemia following hmeatopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 861-866.
12. Uzark K, Grifin L, Rodiguez R, Zamberlan M, Murphy P, Nasman C et al. Quality of life in pediatric heart transplant recipients: a comparison with children with and without heart disease. J Heart Lung Transplant 2012; 31: 571-578.
13. Goldstein SL, Graham N, Burwinkle T, Warady B, Farrah R, Varni JW et al. Health-related quality of life in pediatric patients with ESRD. Pediatr Nephrol 2006; 21: 846-850.
14. Goldstein SL, Graham N, Warady BA, Seikaly M, McDonald R, Burwinkle TM et al. Measuring health-related quality of lie in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory™ (PedsQL™). Am J Kidney Dis 2008; 51: 285-297.
15. Goldstein SL, Rosburg NM, Warady BA, Seikaly M, McDonald R, Limbers C et al. Pediatric end stage renal disease health-related quality of life differs by modality: a PedsQL ESRD analysis. Pediatr Nephrol 2009; 24: 1553-1560.
16. Greinix HT, Loddenkemper C, Pavletic SZ, Holler E, Socie G, Lawitschka A et al. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Biol Blood Marrow Transplant 17: 167-175.
17. Baker KS, Fraser CJ. Quality of life and recovery after graft-versus-host disease. Best Pract Res Clin Haematol 2008; 21: 333-341.
18. Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 2006; 108: 2867-2873.
19. Couriel D, Carpenter PA, Cutler C, Bolanos-Meade J, Treister NS, Gea-Banacloche J et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group report. Biol Blood Marrow Transplant 2006; 12: 375-396.
20. Schultz KR, Miklos DB, Fowler D, Cooke K, Shizuru J, Zorn E et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graftversus- host disease: III. Biomarker Working Group report. Biol Blood Marrow Transplant 2006; 12: 126-137.
21. Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group report. Biol Blood Marrow Transplant 2006; 12: 31-47.
22. Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur J Haematol 2000; 65: 97-103.
23. Lee S, Cook EF, Soiffer R, Antin JH. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 444-452.
24. McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357-368.
25. Pallua S, Giesinger J, Oberguggenberger A, Kemmler G, Nachbaur D, Clausen J et al. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplant 45: 1534-1539.
26. De Civita M, Regier D, Alamgir AH, Anis AH, Fitzgerald MJ, Marra CA et al. Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics 2005; 23: 659-685.
27. Wiener L, Baird K, Crum C, Powers K, Carpenter P, Scott Baker K et al. Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study. Support Care Cancer 2014; 22: 295-305